Skip to main content
Glama

Visualcrossing

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already include readOnlyHint, openWorldHint, idempotentHint, destructiveHint. The description adds valuable behavioral context beyond these: graceful degradation when GLEIF/OpenFIGI is down, explicit handling of unresolved identifiers, and the figi_candidates fallback for ambiguous matches. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is lengthy but well-structured, leading with examples and then detailing supported types and nuances. It is dense and every sentence adds information, though it could be trimmed without loss. It is appropriately detailed for a complex tool but not maximally concise.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a 2-parameter tool with no output schema, the description thoroughly explains behavior: what gets resolved, how sources work, what happens on failure, and what the return contains (e.g., source labels, unresolved field). An agent has everything needed to call it correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% with descriptions for both 'type' and 'value'. The description enriches these by giving concrete examples (e.g., 'AAPL', '0000320193') and clarifying the value semantics for drugs and the bond issuer caution. This exceeds bare schema info.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a clear verb ('resolve') and resource ('entity'), with explicit query examples ('ticker for...', 'CIK for...'). It distinguishes itself from siblings by saying 'Use FIRST whenever you have a name but need an ID' and by noting it replaces 2-3 manual lookups, making its role obvious.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Provides explicit when-to-use guidance: 'Use FIRST whenever you have a name but need an ID.' It also details supported types and inputs, and warns against passing full noun phrases for bonds, which prevents common mistakes. This is clear and actionable.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Visualcrossing toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4.4/5.0
Disambiguation5/5

Each tool has a clearly distinct purpose. Even tools with overlapping domains (e.g., ask_pipeworx and deep_research) are differentiated by use case: single lookups vs multi-faceted research. Weather, Polymarket, memory, and subscription tools are completely separate, and descriptions clarify any potential confusion.

Naming Consistency4/5

Tool names mostly follow a verb_noun pattern, but some are single verbs (forget, recall) or noun_noun (entity_profile, weather_timeline). The mix is noticeable but still predictable and readable, with consistent snake_case formatting throughout.

Tool Count4/5

With 34 tools, the server is large but each tool serves a specific function within the broad data-access domain. The count is justified given the wide range of domains (weather, company data, prediction markets, memory, subscriptions, etc.), though it is on the higher end for typical MCP servers.

Completeness4/5

The tool surface covers a wide range of operations: data retrieval, comparison, fact-checking, weather, prediction markets, memory, subscriptions, and meta-tools. There are no obvious gaps for the intended use of a unified data gateway, though some niche data sources might not be directly addressed.

Resources